Pregled bibliografske jedinice broj: 1184560
The N14 anti-afamin antibody Fab: a rare VL1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservativeversusenthusiastic modelling
The N14 anti-afamin antibody Fab: a rare VL1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservativeversusenthusiastic modelling // Acta Crystallographica Section D Structural Biology, 72 (2016), 12; 1267-1280 doi:10.1107/s205979831601723x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1184560 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The N14 anti-afamin antibody Fab: a rare VL1 CDR
glycosylation, crystallographic re-sequencing,
molecular plasticity and
conservativeversusenthusiastic modelling
Autori
Naschberger, Andreas ; Fürnrohr, Barbara G. ; Lenac Rovis, Tihana ; Malic, Suzana ; Scheffzek, Klaus ; Dieplinger, Hans ; Rupp, Bernhard
Izvornik
Acta Crystallographica Section D Structural Biology (2059-7983) 72
(2016), 12;
1267-1280
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
accuracy ; antibody fragment ; elbow angle ; flexibility ; non-apparent isomorphism ; precision ; solvent ; solvent modelling ; variable-chain glycosylation
Sažetak
The monoclonal antibody N14 is used as a detection antibody in ELISA kits for the human glycoprotein afamin, a member of the albumin family, which has recently gained interest in the capture and stabilization of Wnt signalling proteins, and for its role in metabolic syndrome and papillary thyroid carcinoma. As a rare occurrence, the N14 Fab is N-glycosylated at Asn26L at the onset of the VL1 antigen-binding loop, with the α-1-6 core fucosylated complex glycan facing out of the L1 complementarity-determining region. The crystal structures of two non-apparent (pseudo) isomorphous crystals of the N14 Fab were analyzed, which differ significantly in the elbow angles, thereby cautioning against the overinterpretation of domain movements upon antigen binding. In addition, the map quality at 1.9 Å resolution was sufficient to crystallographically re-sequence the variable VL and VH domains and to detect discrepancies in the hybridoma-derived sequence. Finally, a conservatively refined parsimonious model is presented and its statistics are compared with those from a less conservatively built model that has been modelled more enthusiastically. Improvements to the PDB validation reports affecting ligands, clashscore and buried surface calculations are suggested.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE